The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus plus bicalutamide for castration resistant prostate cancer (CRPC): Bench to bedside and back.
 
Helen Chow
No Relationships to Disclose
 
Paramita Ghosh
No Relationships to Disclose
 
Leandro S D'Abronzo,
No Relationships to Disclose
 
Ralph de Vere White
No Relationships to Disclose
 
Marc Dall'Era
No Relationships to Disclose
 
Christopher P. Evans
Stock and Other Ownership Interests - Medivation; Oncogenex
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation
Research Funding - Medivation
Travel, Accommodations, Expenses - Janssen Oncology; Medivation; Sanofi
 
Stanley A Yap
No Relationships to Disclose
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Astex Pharmaceuticals; Clovis Oncology; Exelixis; Halozyme; Immunogen; Janssen; Medivation; Novartis; Pfizer; Sanofi; Teva; US Diagnostic Services
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Millennium (Inst); Oncogenex (Inst); Polaris (Inst)
 
Chong-Xian Pan
Stock and Other Ownership Interests - Accelerated Medical Diagnostics; LP Therapeutics
Consulting or Advisory Role - Novartis
Research Funding - Abbott Diagnostics; Novartis